BECLOMETHASONE EXTENDS THE RANGE OF ASTHMA THERAPY

InPharma ◽  
1976 ◽  
Vol 61 (1) ◽  
pp. 2-3
Keyword(s):  
Asthma Therapy

Clinical Burden and Predictors of Asthma Exacerbations in Patients on Guideline-based Steps 4-6 Asthma Therapy in the TENOR Cohort

2014 ◽  
Vol 2 (2) ◽  
pp. 193-200.e3 ◽  
Author(s):  
William J. Calhoun ◽  
Tmirah Haselkorn ◽  
David R. Mink ◽  
Dave P. Miller ◽  
Alejandro Dorenbaum ◽  
...  
Keyword(s):  
Asthma Therapy ◽  
Clinical Burden ◽  
Asthma Exacerbations

Pulmonary Delivery of Liposome-Encapsulated Drugs in Asthma Therapy

1995 ◽  
Vol 4 (5) ◽  
pp. 331-337 ◽  
Author(s):  
Ricardo J. Gonzalez-Rothi ◽  
Hans Schreier
Keyword(s):  
Pulmonary Delivery ◽  
Asthma Therapy

Antibody response after varicella vaccination in children treated with budesonide inhalation suspension or non-steroidal conventional asthma therapy

2006 ◽  
Vol 60 (12) ◽  
pp. 1548-1557 ◽  
Author(s):  
K. MURPHY ◽  
K. VERVERELI ◽  
B. M. HARVEY ◽  
A. L. DUKE ◽  
J. CHAPAS-CRILLY ◽  
...  
Keyword(s):  
Antibody Response ◽  
Varicella Vaccination ◽  
Asthma Therapy

scholarly journals Improving Care for Urban Children with Asthma: Design and Methods of the School-Based Asthma Therapy (SBAT) Trial

2008 ◽  
Vol 45 (4) ◽  
pp. 279-286 ◽  
Author(s):  
Jill S. Halterman ◽  
Belinda Borrelli ◽  
Susan Fisher ◽  
Peter Szilagyi ◽  
Lorrie Yoos
Keyword(s):  
Urban Children ◽  
Asthma Therapy ◽  
School Based ◽  
Children With Asthma ◽  
Design And Methods

Hypoglycemia and Cortisol Deficiency Associated With Low-dose Corticosteroid Therapy for Asthma

PEDIATRICS ◽  
1996 ◽  
Vol 97 (6) ◽  
pp. 921-924
Author(s):  
Aaron L. Carrel ◽  
Stephanie Somers ◽  
Robert F. Lemanske ◽  
David B. Allen
Keyword(s):  
Adverse Effects ◽  
Low Dose ◽  
Inhaled Corticosteroids ◽  
Chronic Asthma ◽  
Asthma Therapy ◽  
Biochemical Alterations ◽  
Clinically Significant ◽  
Dose Corticosteroid ◽  
Oral Glucocorticoids ◽  
Cortisol Deficiency

Glucocorticoids are a cornerstone of the anti-inflammatory treatment of asthma. To minimize adverse effects of oral glucocorticoids (OGC), clinicians have used alternate-day oral or inhaled corticosteroids (IC), both generally considered safe for chronic asthma therapy in children. Although reversible growth suppression occasionally occurs, the general consensus is that, despite detectable biochemical alterations, these modes of therapy are not associated with clinically significant adrenal insufficiency.1 We report the occurrence of hypoglycemia due to cortisol deficiency during combination alternate-day oral and inhaled corticosteroids. CASE HISTORY A 3½-year-old boy with asthma was found one morning to be unarousable, limp, and blue around the lips.

Inadequate Therapy for Asthma Among Children in the United States

PEDIATRICS ◽  
2000 ◽  
Vol 105 (Supplement_2) ◽  
pp. 272-276
Author(s):  
Jill S. Halterman ◽  
C. Andrew Aligne ◽  
Peggy Auinger ◽  
John T. McBride ◽  
Peter G. Szilagyi
Keyword(s):  
Severe Asthma ◽  
Asthma Management ◽  
The United States ◽  
Asthma Therapy ◽  
National Guidelines ◽  
Cross Sectional ◽  
Asthma Morbidity ◽  
The Past ◽  
Maintenance Medication ◽  
Inadequate Therapy

Objective. Childhood asthma morbidity and mortality are increasing despite improvements in asthma therapy. We hypothesized that a substantial number of children with moderate to severe asthma are not taking the maintenance medications recommended by national guidelines. The objective of this study was to describe medication use among US children with asthma and determine risk factors for inadequate therapy. Methods. The National Health and Nutrition Examination Survey (NHANES) III 1988–1994 provided cross-sectional, parent-reported data for children 2 months to 16 years of age. Analysis focused on children with moderate to severe asthma (defined as having any hospitalization for wheezing, ≥2 acute visits for wheezing, or ≥3 episodes of wheezing over the past year). We defined these children as adequately treated if they had taken a maintenance medication (inhaled corticosteroid, cromolyn, or theophylline) during the past month. Demographic variables were analyzed for independent associations with inadequacy of therapy. The statistical analysis used SUDAAN software to account for the complex sampling design. Results. A total of 1025 children (9.4%) had physician-diagnosed asthma. Of those with moderate to severe asthma (n = 524), only 26% had taken a maintenance medication during the past month. Even among children with 2 or more hospitalizations over the previous year, only 32% had taken maintenance medications. In a logistic regression analysis, factors significantly associated with inadequate therapy included: age ≤5 years, Medicaid insurance, and Spanish language. Children surveyed after 1991, when national guidelines for asthma management became available, were no more likely to have taken maintenance medications than children surveyed before 1991. Conclusion. Most children with moderate to severe asthma in this nationally representative sample, including those with multiple hospitalizations, did not receive adequate asthma therapy. These children may incur avoidable morbidity. Young children, poor children, and children from Spanish-speaking families appear to be at particularly high risk for inadequate therapy.

scholarly journals Asthma therapy in the new millennium

2000 ◽  
Vol 49 (4) ◽  
pp. 231-236 ◽  
Author(s):  
Stephen T Holgate
Keyword(s):  
Asthma Therapy ◽  
New Millennium
Sign in / Sign up

Export Citation Format

Share Document